論文・技術情報追加のお知らせ

1. Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US food and drug administration's adverse event reporting system.

アバトロンボパグの副作用をFAERSで調査

対象DB：FAERS

2. Exploring the Link Between Exogenous Thyroid Hormones and Dementia Symptoms: A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System.

ETH療法と認知症症状の関連性が示唆される。医師は用量や経過観察に注意を払う必要あり

対象DB：FAERS

3. Exploring adverse events of Vilazodone: evidence from the FAERS database.

ビラゾドンの安全性評価。新たな睡眠障害や性機能障害のリスクに警戒が必要

対象DB：FAERS

4. Risk of drug-induced delirium in older patients- a pharmacovigilance study of FDA adverse event reporting system database.

FAERSによると、高齢者における薬剤性せん妄リスクは広範囲に存在

対象DB：FAERS

5. Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study.

CDK4/6阻害剤の血液学的有害事象リスクはばらつきあり

対象DB：FAERS

6. Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system.

NSCLC治療のICI戦略は副作用プロファイルに差があり、治療戦略の改善に役立つ可能性

対象DB：FAERS

7. Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system.

アブロシチニブは予期せぬ重篤な副作用も報告されている

対象DB：FAERS

8. Brivaracetam-Associated Rhabdomyolysis Requiring Renal Replacement Therapy: A Case Report and Review of the Literature.

ブリバラセタムは稀に致命的な横紋筋融解症を引き起こす可能性

対象DB：FAERS

9. Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study.

PDE5阻害薬は眼の副作用リスク増、種類別に異なる影響あり

対象DB：FAERS

10. Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database.

アブロシチニブはAD治療中に希少な副作用が発生する可能性あり

対象DB：FAERS

11. Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.

GLP-1 RAsは甲状腺腫瘍リスク増加

対象DB：FAERS

12. The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database.

PDE5阻害薬が動脈疾患リスク増

対象DB：VigiBase

13. Relationship of oral bacterial number with medical hospitalization costs in analysis of Diagnosis Procedure Combination database from single institution in Japan.

口腔細菌数が入院医療費に影響

対象DB：DPC

14. Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.

2021年8月のCOVID-19波は医療資源を逼迫

対象DB：NDB

15. Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK.

UKでEGPA有病率増加、医療負担大

対象DB：CPRD

16. Epidemiology of SLE in Italy: an observational study using a primary care database.

イタリアのSLE発症率と有病率が増加

対象DB：THIN